Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Tissue Antigens|July 24, 2002
Identification of a novel HLA-DRB1 allele, DRB1*0108, by sequence-based DRB typing in two siblingsM Martinez-Gallo, L Martinez-Lostao, M A Martinez-Carretero, et al.
Targeted Oncology|November 16, 2016
Resistance to Targeted Therapies in Renal Cancer: The Importance of Changing the Mechanism of ActionI Duran, J Lambea, P Maroto, et al.
Actas Urologicas Espanolas|September 25, 2012
[Recomendations on the management of controversies in advanced castrate-resistant prostate cancer]J M Cózar, E Solsona, J Morote, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 6, 2016
SEOM clinical guidelines for the management of germ cell testicular cancer (2016)J Aparicio, J Terrasa, I Durán, et al.
Oncotargets and Therapy|October 17, 2017
HIF pathway and c-Myc as biomarkers for response to sunitinib in metastatic clear-cell renal cell carcinomaP Maroto, E Esteban, E Fernández Parra, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 20, 2018
SEOM clinical guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2018)A González Del Alba, G De Velasco, N Lainez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 30, 2005
Multicentre risk-adapted management for stage I non-seminomatous germ cell tumoursP Maroto, X García del Muro, J Aparicio, et al.
British Journal of Cancer|March 5, 2002
Phase II multicentre study of docetaxel plus cisplatin in patients with advanced urothelial cancerX Garcia del Muro, E Marcuello, J Gumá, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 30, 2013
Phase II trial of sequential subcutaneous interleukin-2 plus interferon alpha followed by sorafenib in renal cell carcinoma (RCC)J P Maroto, X G del Muro, B Mellado, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 24, 2021
SEOM clinical guidelines for the treatment of advanced prostate cancer (2020)A González Del Alba, M J Méndez-Vidal, S Vazquez, et al.
Pageof 6